Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trialKohei Shitara, Min‐Hee Ryu, Lorenzo Fornaro et al.|The Lancet|2018Cited by 1.3k
An update on treatment options for pancreatic adenocarcinomaAurélien Lambert, Thierry Conroy, Lilian Schwarz et al.|Therapeutic Advances in Medical Oncology|2019Cited by 211
Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatographyJacques Devière, Marielle Cohard, Olivier Le Moine et al.|Gastroenterology|2001Cited by 196